First-line Antiretroviral Therapy and Changes in Lipid Levels Over 3 Years Among HIV-Infected Adults in Tanzania | Zendy

Enju Liu | Zendy; Catharina Armstrong | Zendy; Donna Spiegelman | Zendy; Guerino Chalamilla | Zendy; Marijelekela | Zendy; Claudia Hawkins | Zendy; Ellen Hertzmark | Zendy; Nan Li | Zendy; Eric Aris | Zendy; Alfa Muhihi | Zendy; Helen Semu | Zendy; Wafaie Fawzi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

First-line Antiretroviral Therapy and Changes in Lipid Levels Over 3 Years Among HIV-Infected Adults in Tanzania

Author(s) -

Enju Liu,

Catharina Armstrong,

Donna Spiegelman,

Guerino Chalamilla,

Marijelekela,

Claudia Hawkins,

Ellen Hertzmark,

Nan Li,

Eric Aris,

Alfa Muhihi,

Helen Semu,

Wafaie Fawzi

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit120

Subject(s) - nevirapine , stavudine , medicine , efavirenz , dyslipidemia , zidovudine , cholesterol , triglyceride , antiretroviral therapy , gastroenterology , human immunodeficiency virus (hiv) , immunology , viral load , obesity , viral disease

With the rapid rollout of antiretroviral therapy (ART) in sub-Saharan Africa (SSA), there has been an increasing concern about cardiovascular risks related to ART. However, data from human immunodeficiency virus (HIV)-infected populations from this region are very limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research